Circulating tumor cells in non-metastatic triple-negative breast cancer

Circulating tumor cells (CTCs) can be identified in approximately 25 % of stage I-III breast cancer patients; CTCs presence is a predictor of poor outcome in metastatic breast cancer, but little is known regarding the prognostic significance of CTCs in non-metastatic triple-negative breast cancer (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Karhade, Mandar, Hall, Carolyn, Mishra, Priyankana, Anderson, Amber, Kuerer, Henry, Bedrosian, Isabelle, Krishnamurthy, Savitri, Lucci, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149877/
https://www.ncbi.nlm.nih.gov/pubmed/25164970
http://dx.doi.org/10.1007/s10549-014-3103-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149877/
https://www.ncbi.nlm.nih.gov/pubmed/25164970
http://dx.doi.org/10.1007/s10549-014-3103-7

Ejemplares similares